凯文-2促进纤维细胞转移到肌纤维细胞的转移差异化,并加剧心脏纤维化
Yusuke Higuchi1, Takehiro Ogata1,2, Naohiko Nakanishi1
1Department of Cardiovascular Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
ESC heart failure
|October 24, 2023
概括
卡-2 缺乏通过抑制纤维细胞激活和转化增长因子-β (TGF-β) 信号传递,显著减少心脏纤维化. 这一发现表明Cavin-2是治疗心脏纤维化的潜在治疗标.
科学领域:
- 心血管生物学 心血管生物学
- 细胞信号传输 细胞信号传输
- 纤维化研究 纤维化研究
背景情况:
- 转化增长因子-β (TGF-β) 信号传递对于纤维细胞激活和心脏纤维化至关重要.
- 洞穴蛋白和洞穴蛋白调节TGF-β信号传递;Cavin-2在纤维细胞中丰富,但其在心脏纤维化中的作用尚不清楚.
研究的目的:
- 阐明Cavin-2在纤维细胞激活和心脏纤维化中的参与和功能.
- 研究Cavin-2对心脏纤维细胞TGF-β/Smad信号通路的影响.
主要方法:
- 在野生型,Cavin-2无效和Cavin-2条件淘汰小鼠中利用横向大动脉收缩 (TAC).
- 隔离小鼠胚胎纤维细胞 (MEF) 来评估纤维细胞转差和TGF-β信号传递.
- 量化心脏纤维化,原沉积,αSMA表达和Smad2酸化.
主要成果:
- 与对照组相比,Cavin-2淘汰赛小鼠在TAC后显著减少心脏纤维化.
- 对Cavin-2减弱纤维细胞的损失导致肌纤维细胞分化和抑制纤维化相关的基因表达 (Col1a1,Ctgf,Col3).
- 卡-2 缺乏导致TGF-β1诱导的Smad2酸化受损,并降低了MEF中的热冲击蛋白90水平.
结论:
- 卡-2 枯竭抑制心脏纤维细胞激活和通过TGF-β/Smad通路转化为肌纤维细胞的转差.
- 针对心脏纤维细胞中的Cavin-2提供了一种有前途的策略,可以缓解心脏纤维化,并可能保持心脏功能.
相关概念视频
Myocarditis I: Introduction
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...


